The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 10, 2017
Filed:
Aug. 01, 2014
Applicant:
Synageva Biopharma Corp., Lexington, MA (US);
Inventors:
Anthony Quinn, Chestnut Hill, MA (US);
Alex J. Harvey, Athens, GA (US);
Zhinan Xia, Wellesley, MA (US);
Assignee:
ALEXION PHARMACEUTICALS, INC., New Haven, CT (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 9/96 (2006.01); C12N 15/00 (2006.01); C12N 15/52 (2006.01); C12N 15/63 (2006.01); C12N 15/85 (2006.01); C12N 9/16 (2006.01); C12N 9/00 (2006.01); C12N 9/22 (2006.01);
U.S. Cl.
CPC ...
C12N 9/16 (2013.01); C12N 9/00 (2013.01); C12N 9/22 (2013.01); C12N 9/96 (2013.01); C07K 2319/00 (2013.01); C07K 2319/01 (2013.01); C07K 2319/02 (2013.01); C07K 2319/33 (2013.01); C12Y 301/04001 (2013.01); Y10S 530/827 (2013.01);
Abstract
The present invention provides a novel fusion polypeptide containing a catalytic portion of NPP1 fused to a targeting moiety, nucleic acids encoding the fusion polypeptide, a vector containing the nucleic acid integrated thereinto, a host cell transformed with the vector and pharmaceutical compositions comprising the fusion polypeptide.